Closing the Gap: Addressing the Gout and Kidney Disease Cycle

The February 2026 workshop brought together nephrologists, rheumatologists, and patients to confront a clinical environment where gout is often mismanaged. Experts, including co-chairs Dr. David Mount and Dr. Angelo Gaffo, noted that the condition is frequently reduced to a lifestyle issue, ignoring the underlying biological reality of uric acid retention in compromised kidneys. This stigma often delays life-saving interventions, as patients hesitate to seek care for symptoms they are told are their own fault.

Dr. Joseph Vassalotti, Chief Medical Officer at the National Kidney Foundation, emphasized that effective management requires a two-stage approach: immediate relief from acute, painful flares followed by long-term strategies to prevent recurrence. The current challenge lies in balancing medication efficacy with the limitations of reduced renal function. The foundation plans to release a comprehensive report later this year to standardize care and guide future research, aiming to move beyond outdated myths and provide patients with personalized, evidence-based treatment plans.